ICD9Data.com
  Free 2008 ICD-9-CM Database
Search ICD9Data.com

2008 ICD-9-CM Procedure 99.25

Injection or infusion of cancer chemotherapeutic substance
  • A procedure in which the blood supply to the tumor is blocked surgically or mechanically and anticancer drugs are administered directly into the tumor. This permits a higher concentration of drug to be in contact with the tumor for a longer period of time.
  • 99.25 is a specific code that can be used to specify a procedure
  • 99.25 contains 16 index entries
  • View the full ICD-9-CM Volume 3 99.* hierarchy

99.25 also known as:

  • Chemoembolization
  • Injection or infusion of antineoplastic agent

99.25 excludes:

  • immunotherapy, antineoplastic (00.15, 99.28)
  • implantation of chemotherapeutic agent (00.10)
  • injection of radioisotope (92.28)
  • injection or infusion of biological response modifier [BRM] as an antineoplastic agent (99.28)

Index entries containing 99.25:

Chemoembolization 99.25
    Chemotherapy - see also Immunotherapy
    • for cancer NEC 99.25
      • brain wafer implantation 00.10
        • implantation of chemotherapeutic agent 00.10
          • interstitial implantation 00.10
            • intracavitary implantation 00.10
              • wafer chemotherapy 00.10
              Embolization (transcatheter)
              • chemoembolization 99.25
                Infusion (intra-arterial) (intravenous)
                • antineoplastic agent (chemotherapeutic) 99.25
                  • biological response modifier [BRM] 99.28
                    • cintredekin besudotox 99.28
                      • high-dose interleukin-2 00.15
                        • low-dose interleukin-2 99.28
                        • cancer chemotherapy agent NEC 99.25
                          Injection (into) (hypodermically) (intramuscularly) (intravenously) (acting locally or systemically)
                          • Actinomycin D, for cancer chemotherapy 99.25
                            • antineoplastic agent (chemotherapeutic) NEC 99.25
                              • biological response modifier [BRM] 99.28
                                • cintredekin besudotox 99.28
                                  • high-dose interleukin-2 00.15
                                    • low-dose interleukin-2 99.28
                                    • BCG
                                      • for chemotherapy 99.25
                                      • cancer chemotherapeutic agent 99.25
                                        • Methotrexate, for cancer chemotherapy 99.25
                                          • sclerosing agent NEC 99.29
                                            • treatment of malignancy (cytotoxic agent) 34.92 [99.25]
                                          Perfusion NEC 39.97
                                          • for
                                            • chemotherapy NEC 99.25
                                            Pleurodesis 34.6Pleurosclerosis 34.6ScarificationSclerotherapy